In particular, treatment with carbamazepine is strongly associated with a high risk of developing Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) in carriers of the HLA-B*1502 allele. The gene discussed is HLA-B; the disease is Schwartz-Jampel syndrome.